We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.52%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+64.52%
3 Year Est. Return
+233.32%
5 Year Est. Return
+564.3%
10 Year Est. Return
+5,313.55%
AUM
$674M
AUM Growth
+$8.35M
Cap. Flow
-$1.92M
Cap. Flow %
-0.28%
Top 10 Hldgs %
32.57%
Holding
355
New
76
Increased
41
Reduced
27
Closed
58

Top Buys

Rank Stock Value
1
PEN icon
Penumbra
PEN
+$17.5M
2
WBD icon
Warner Bros
WBD
+$14.3M
3
MASI
Masimo
MASI
+$13.9M
4
ACLX
Arcellx
ACLX
+$13.5M
5
CWAN
Clearwater Analytics
CWAN
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.33%
2 Communication Services 15.36%
3 Financials 14.69%
4 Industrials 10.92%
5 Technology 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENVR
276
Gen Digital Inc Contingent Value Rights
GENVR
$18K ﹤0.01%
38,300
CCIIW
277
Cohen Circle Acquisition Corp II Warrant
CCIIW
$5.2M
$16.2K ﹤0.01%
24,950
XRX icon
278
Xerox
XRX
$357M
$15.5K ﹤0.01%
12,000
DTSQR
279
DT Cloud Star Acquisition Corp Right
DTSQR
$15.2K ﹤0.01%
116,000
DMIIR
280
Drugs Made In America Acquisition II Corp Right
DMIIR
$14.4K ﹤0.01%
+179,500
New +$20.4K
SDAWW
281
SunCar Technology Group Warrant
SDAWW
$12.3M
$11.8K ﹤0.01%
47,400
GMHS
282
Gamehaus Holdings
GMHS
$49.1M
$10.2K ﹤0.01%
11,440
UYSCR
283
UY Scuti Acquisition Corp Rights
UYSCR
$9.25K ﹤0.01%
57,800
MBAVW
284
DELISTED
M3-Brigade Acquisition V Corp Warrant
MBAVW
$8.58K ﹤0.01%
28,750
CCIXW
285
Churchill Capital Corp IX Warrant
CCIXW
$32.3K
$7.53K ﹤0.01%
16,725
OBAWW
286
Oxley Bridge Acquisition Ltd Warrants
OBAWW
$6.98K ﹤0.01%
34,900
LWACW
287
LightWave Acquisition Corp Warrants
LWACW
$2.37M
$6.65K ﹤0.01%
27,700
ANSCW
288
Agriculture & Natural Solutions Acquisition Corp Warrant
ANSCW
$4.99K ﹤0.01%
24,950
GRML
289
Greenland Mines Ltd
GRML
$28.8M
$3.3K ﹤0.01%
10,000
DMAAR
290
Drugs Made In America Acquisition Corp Rights
DMAAR
$2.9K ﹤0.01%
+48,100
New +$5.09K
CXAIW icon
291
CXApp Inc Warrant
CXAIW
$2.66K ﹤0.01%
83,053
SPKLW
292
Spark I Acquisition Corp Warrant
SPKLW
$7.55M
$2.28K ﹤0.01%
12,650
ALCYW
293
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$1.93K ﹤0.01%
12,050
OSRHW
294
OSR Health Warrant
OSRHW
$1.15K ﹤0.01%
20,800
MSAIW icon
295
MultiSensor AI Holdings Warrant
MSAIW
$656K
$974 ﹤0.01%
24,900
SLXNW
296
Silexion Therapeutics Warrant
SLXNW
$276K
$774 ﹤0.01%
38,150
BNZIW icon
297
Banzai International Warrant
BNZIW
$131K
$167 ﹤0.01%
12,711
ABVX
298
Abivax
ABVX
$11.2B
-1,625
Closed -$219K
ACI icon
299
Albertsons Companies
ACI
$5.57B
-77,745
Closed -$1.33M
ALEX
300
DELISTED
Alexander & Baldwin
ALEX
-62,100
Closed -$1.28M

Similar funds

Gabelli & Co Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Gabelli & Co Investment Advisers held 355 positions worth $674M, up 1.3% from $666M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers's Q1 2026 filing shows 76 new, 41 increased, 27 reduced and 58 closed positions. Its largest new stake was Penumbra: 51,692 shares worth $17M. The largest sale was Dayforce, an estimated $26.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Communication Services and Financials.

  • Gabelli & Co Investment Advisers's largest Q1 2026 buy was Penumbra: 51,692 shares worth $17M.
  • Gabelli & Co Investment Advisers added most to Warner Bros in Q1 2026, an estimated $14.3M increase.
  • Gabelli & Co Investment Advisers's biggest Q1 2026 reduction was Fox Class B, cutting an estimated $4.62M.
  • Gabelli & Co Investment Advisers fully exited Dayforce in Q1 2026, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $674M portfolio in Q1 2026.
  • Gabelli & Co Investment Advisers opened 76 new positions and closed 58 in Q1 2026.
  • Gabelli & Co Investment Advisers's portfolio value rose 1.3% quarter-over-quarter to $674M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.